The results further confirm that ACE can increase the proportion of T-lps in the peripheral blood of colon cancer patients, especially CD3+ and CD4+ T cells, regulate the balance of Th1/Th2 cells, and thus exert anti-tumor effects. This evidence concerns the gene CD4 and malignant colon neoplasm.